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New accessible sonochemical methods were developed for the functionalization of synthesized
graphene oxide (GO) with copper/iron compounds and drug intercalation into their structure in
aqueous solution at ambient conditions by using ultrasound (20 kHz) treatment. The sono-
chemical formation mechanism of a new nanomaterial was revealed through the structural
analysis of three types of nanocomposites: (i) copper@graphene oxide, (ii) copper/iron@-
graphene oxide and (iii) iron@graphene oxide. Unique copper/iron-modi¯ed graphene oxide
nanocomposites can be used as nanocarriers for the anti-in°ammatory drug (ketorolac) delivery
in aqueous solution due to the reduced submicron size and enlarged surface area. Disintegration
of the ultrasonically intercalated ketorolac followed the exponential decay curve ¯t at higher pH
values of the aqueous solution with a higher decay constant observed in copper/iron-modi¯ed
graphene oxide nanocomposites.
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1. Introduction
Nonsteroidal anti-in°ammatory drugs (NSAIDs)
are among the most commonly prescribed medica-
tions worldwide to treat the in°ammation and
pain, thereby reducing fever and inhibiting a
thrombocyte aggregation. Among many NSAIDs,
ketorolac is the most potent and e®ective analgesic
to be used after surgery with e±cacy comparable to
opioids. However, when the drug is delivered to the
human body through the gastro-intestinal system,
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the latter undergoes bleeding and develops gastritis
after repeated doses of ketorolac over prolonged
duration. Much research e®orts are being put to-
ward administration of ketorolac at a lower dose
while maintaining its therapeutic e±cacy.
The anti-in°ammatory activity of NSAIDs can be
enhanced through the formation of Cu(II) complexes
with drugs functionalized with the carboxylate group
acting as a bridging bidentate ligand involving Cu–O
and Cu–Cu bonds in the complexes involving enzyme
superoxide dismutase (SOD). The complexation of
NSAIDs with Fe(II) among other materials leads to
the scavenging of free radicals (including oxygen)
and results in an enhanced gastric protection.
Graphene oxide (GO) in its pristine or modi¯ed
form can be used as a successful drug molecular
carrier due to its high surface area, biocompatibility
and a very rich surface chemistry providing carbonyl,
epoxide and carboxyl groups. GO as a molecular
carrier can improve the bioavailability of drugs and
decrease the dose of administration due to surface
modi¯cation and reduction of the particle size.
There is a powerful technique in nanotechnology
to modify GO with copper/iron compounds and
transform this system into smart molecular carrier
for healthier ketorolac administration. This method
is based on sonochemistry that arises from acoustic
cavitation: the formation, growth and implosive
collapse of bubbles in liquid subjected to ultrasound
treatment. The interfacial region of these bubbles
has a temperature of 103 K, pressure of 108 Pa
and very high gradients of shear forces that can be
used for a particle size reduction, chemical reduc-
tion/oxidation of Cu or Fe on the GO surface and
drug intercalation.
The present paper aims at (i) illuminating sono-
chemistry as a nanotechnology tool for functionali-
zation of GO with copper, copper/iron and iron
compounds; (ii) intercalating ketorolac into these
unique nanocomposites by ultrasound treatment
(20 kHz, 18W/cm2Þ; (iii) ¯nding out parameters of
the ketorolac disintegration in the aqueous phase by
using its prominent Raman peak at 1328 cm1.
2. Results and Discussion
2.1. Sonochemical formation of copper/
iron-modi¯ed graphene oxide
nanocomposites
Graphene oxide nano°akes were synthesized from
graphite by using an improved Hummers method1
[Fig. 1(a)]. The synthesized nano°akes with a
smooth morphology and submicron size were sono-
chemically modi¯ed with copper2 [Fig. 1(b)], cop-
per/iron [Fig. 1(c)] and iron [Fig. 1(d)] compounds.
Fig. 1. Representative SEM images of (a) synthesized GO; and sonochemically prepared (b) copper-, (c) copper/iron- and (d) iron-
modi¯ed@GO nanocomposites.




































































































Copper@GO particles have an average diameter
of  600 nm [relative standard deviation (r.s.d.)
30%], copper/iron@GO particles acquire  580 nm
(r.s.d.16%) and iron@GO particles obtain
 460 nm (r.s.d.3%). Surface chemical composi-
tion and bonding of GO and its nanocomposites
were investigated by XPS (Fig. 2).
Synthesized GO is composed of carbon- and
oxygen-containing surface groups: carbonyl (R–
C¼O–R 0), epoxide (R–C–O–C–R 0) and carboxyl
(C(¼O)OH) [Fig. 2(a)]. The surfaces of copper-
@GO, copper/iron@GO and iron-@GO nano-
composites are enriched with carbon, oxygen and
oxygen-containing compounds, indicating oxide
phases on GO [Fig. 2(b)–2(d)].
The XPS analysis of Cu-2p lines reveals the
main component peaks for the Cuþ [i.e., Cu(I)] in
copper-@GO and copper/iron-@GO nanocompo-




the GO surface (curves B and C in Fig. 2). The
presence of Cu2þ [i.e., Cu(II)] state demonstrates
the formation of Cu2þS2–, Cu2þO2 in the cop-
per@GO nanocomposite (curves B in Fig. 2).
The XPS analysis of Fe-2p line in copper/
iron@Go and iron@GO nanocomposites reveals a
doublet implying the presence of hydrated iron
oxide or ferric oxidation products (curves c and d
in Fig. 2). This doublet may be indicative for
Fe2þO2, hematite -Fe2O3, -Fe2O3 or hydroxyl-
oxide FeO(OH) with an intermediate composition
between goethite -FeOOH and -Fe2O3. Small
satellite peaks (at  719:8 eV and  733:2 eV) ap-
pear only in copper/iron@GO nanocomposite, im-
plying an existence of Fe3þ in FeO(OH) and Fe2O3.
2.2. Sonochemical intercalation
of ketorolac
The anti-in°ammatory drug ketorolac was inter-
calated in the GO and copper-, copper/iron- or
iron-modi¯ed@GO nanocomposites by ultrasound
treatment (3min at 8W/cm2 and 20 kHz) in the
Fig. 2. XPS spectra of C-1s, Cu-2p and Fe-2p lines of (a) synthesized GO, (b) copper@GO, (c) copper/iron@GO and (d) iron@GO
nanocomposites.




































































































aqueous solution. The sonochemical intercalation of
ketorolac was examined by Raman spectroscopy
(Fig. 3).
Raman spectra reveal the most intense peak
of ketorolac (1328 cm1Þ along with the two prom-
inent D and G bands of GO in the copper/iron@GO
nanocomposite after sonication. In contrast, these
Raman peaks are weaker in GO after sonication
with ketorolac, demonstrating higher intercalation
e±ciency in the copper/iron@GO nanocomposite.
2.3. Ketorolac disintegration test
We applied a disintegration test of ketorolac being
sonochemically intercalated into GO, copper@GO,
copper/iron@GO and iron@GO nanocomposites in
aqueous solutions adjusted to the pH values of 1, 5
and 8. The drug disintegration was examined via
the intensity decrease of the prominent Raman peak
of ketorolac (1328 cm1Þ (Fig. 4).
Disintegration of the intercalated ketorolac oc-
curred at higher pH values of aqueous solution and
much faster from iron@GO nanocomposites.
3. Conclusion
New accessible sonochemical method was developed
for the functionalization of graphene oxide with
copper, copper/iron and iron compounds in aqueous
solutions at ambient conditions. Unique nano-
composites can be sonochemically intercalated with
the anti-in°ammatory drug ketorolac. Among them
copper/iron@GO can act as the most e±cient
nanocarrier due to e®ective intercalation of ketor-
olac into its structure and its much slower disinte-
gration at high pH values of the solution.
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Fig. 3. Averaged representative Raman spectra of synthesized
GO (A) and ketorolac powder (B) before sonication; and GO
with ketorolac (C) and copper/iron@GO nanocomposite with
ketorolac (D) after ultrasonic treatment in water. The arrows
indicate the prominent Raman peak of ketorolac (1328 cm1Þ
and the characteristic D and G Raman modes of GO
(1360 cm1 and 1606 cm1Þ.
Fig. 4. Experimental data of normalized intensity at
1328 cm1 in the aqueous solutions of GO, copper@GO, cop-
per/iron@GO and iron@GO nanocomposites with intercalated
ketorolac before and after incubation at pH = 1, 5 and 8. These
data were ¯tted to exponential decay curves, revealing the
decay constants to be 0.6 (copper/iron@GO), 0.5 (GO), 0.4
(copper@GO) and 0.1 (iron@GO), respectively.
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